Literature DB >> 26472336

Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine.

Wisam Alwan1, Frank O Nestle2.   

Abstract

Psoriasis is a common, chronic inflammatory skin disease associated with multi-system manifestations including arthritis and obesity. Our knowledge of the aetiology of the condition, including the key genomic, immune and environmental factors, has led to the development of targeted, precision therapies that alleviate patient morbidity. This article reviews the key pathophysiological pathways and therapeutic targets and highlights future areas of interest in psoriasis research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26472336

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  26 in total

Review 1.  [Pathogenesis of psoriasis].

Authors:  K Schäkel; M P Schön; K Ghoreschi
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 2.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 3.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

4.  Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".

Authors:  Matteo Megna; Anna Balato; Maddalena Napolitano; Lucia Gallo; Francesco Caso; Luisa Costa; Nicola Balato; Raffaele Scarpa
Journal:  Clin Rheumatol       Date:  2018-04-11       Impact factor: 2.980

5.  Extracellular ATP and IL-23 Form a Local Inflammatory Circuit Leading to the Development of a Neutrophil-Dependent Psoriasiform Dermatitis.

Authors:  Julio A Diaz-Perez; Meaghan E Killeen; Yin Yang; Cara D Carey; Louis D Falo; Alicia R Mathers
Journal:  J Invest Dermatol       Date:  2018-06-02       Impact factor: 8.551

Review 6.  Innate lymphoid cells in autoimmunity and chronic inflammatory diseases.

Authors:  Tingting Xiong; Jan-Eric Turner
Journal:  Semin Immunopathol       Date:  2018-03-22       Impact factor: 9.623

Review 7.  Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of Patients with Moderate-Severe Psoriasis and Concomitant Diseases.

Authors:  Ana Ion; Alexandra Maria Dorobanțu; Liliana Gabriela Popa; Mara Mădălina Mihai; Olguța Anca Orzan
Journal:  Biology (Basel)       Date:  2022-05-25

Review 8.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

Review 9.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 10.  [Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa].

Authors:  M von Laffert; R E Hunger; A A Navarini; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-02       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.